Nasal allergies in the Asian - Pacific population: Results from the Allergies in Asia-Pacific Survey

Constance H. Katelaris, Christopher K.W. Lai, Chae Seo Rhee, Sang Hag Lee, Wang De Yun, Linda Lim-Varona, Vo Thanh Quang, Jason Hwang, Harvinder Singh, Jungsoo Kim, John M. Boyle, Hun Jong Dhong, Prepageran Narayanan, Gil Vicente, Michael Blaiss, Raymond Sacks

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: The Allergies in Asia - Pacific Survey describes the symptoms, impact, and treatment of allergic rhinitis (AR) across Australia, China, Hong Kong, Malaysia, Singapore, Taiwan, Vietnam, and the Philippines. The Allergies in Asia - Pacific Survey was undertaken to further clarify the prevalence of physician-diagnosed nasal allergies (NAs), impact on quality-of-life (QOL), existing treatment paradigms and gaps, and NA medications currently used in treatment. Methods: Thirty-three thousand three hundred seventy-eight households were screened for individuals, ≥4 years old, with a physician diagnosis of AR or NA and either symptoms or treatment in the past 12 months. Standardized questionnaires were used to make comparisons across regions. A total of 1043 adults and 192 children were included in the survey. Results: Nine percent of participants were diagnosed with AR with two of three responding that their NAs were seasonal in nature. Nasal congestion was the most common and bothersome symptom of AR. Most participants reported that AR impacted their QOL with nearly one-half citing impairments in school/work performance/productivity. Sleep disturbances, secondary to AR, were also shown to be appreciable. Two-thirds of patients took medication for their AR. Less than one-quarter of survey respondents reported taking an intranasal corticosteroid and the satisfaction rate was similar to that of over-the-counter medications. The most common reasons cited for dissatisfaction were related to inadequate efficacy and bothersome side effects. Conclusion: AR appears to be extremely common across Asia - Pacific nations. Many individuals with AR suffer from symptoms that reduce QOL and treatment gaps exist with current therapies. Through identification of disease impact and highlighting treatment gaps, clinicians may better understand and treat AR, leading to improvements in overall patient satisfaction and QOL.

Original languageEnglish
JournalAmerican Journal of Rhinology and Allergy
Volume25
Issue number5 SUPPL. 1
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

Nose
Hypersensitivity
Population
Quality of Life
Therapeutics
Surveys and Questionnaires
Allergic Rhinitis
Physicians
Philippines
Vietnam
Malaysia
Singapore
Hong Kong
Patient Satisfaction
Taiwan
China
Adrenal Cortex Hormones
Sleep

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Nasal allergies in the Asian - Pacific population : Results from the Allergies in Asia-Pacific Survey. / Katelaris, Constance H.; Lai, Christopher K.W.; Rhee, Chae Seo; Lee, Sang Hag; De Yun, Wang; Lim-Varona, Linda; Quang, Vo Thanh; Hwang, Jason; Singh, Harvinder; Kim, Jungsoo; Boyle, John M.; Dhong, Hun Jong; Narayanan, Prepageran; Vicente, Gil; Blaiss, Michael; Sacks, Raymond.

In: American Journal of Rhinology and Allergy, Vol. 25, No. 5 SUPPL. 1, 01.09.2011.

Research output: Contribution to journalArticle

Katelaris, CH, Lai, CKW, Rhee, CS, Lee, SH, De Yun, W, Lim-Varona, L, Quang, VT, Hwang, J, Singh, H, Kim, J, Boyle, JM, Dhong, HJ, Narayanan, P, Vicente, G, Blaiss, M & Sacks, R 2011, 'Nasal allergies in the Asian - Pacific population: Results from the Allergies in Asia-Pacific Survey', American Journal of Rhinology and Allergy, vol. 25, no. 5 SUPPL. 1. https://doi.org/10.2500/ajra.2011.25.3674
Katelaris, Constance H. ; Lai, Christopher K.W. ; Rhee, Chae Seo ; Lee, Sang Hag ; De Yun, Wang ; Lim-Varona, Linda ; Quang, Vo Thanh ; Hwang, Jason ; Singh, Harvinder ; Kim, Jungsoo ; Boyle, John M. ; Dhong, Hun Jong ; Narayanan, Prepageran ; Vicente, Gil ; Blaiss, Michael ; Sacks, Raymond. / Nasal allergies in the Asian - Pacific population : Results from the Allergies in Asia-Pacific Survey. In: American Journal of Rhinology and Allergy. 2011 ; Vol. 25, No. 5 SUPPL. 1.
@article{ffacf4611e384db6a164f1cde2c99b8b,
title = "Nasal allergies in the Asian - Pacific population: Results from the Allergies in Asia-Pacific Survey",
abstract = "Background: The Allergies in Asia - Pacific Survey describes the symptoms, impact, and treatment of allergic rhinitis (AR) across Australia, China, Hong Kong, Malaysia, Singapore, Taiwan, Vietnam, and the Philippines. The Allergies in Asia - Pacific Survey was undertaken to further clarify the prevalence of physician-diagnosed nasal allergies (NAs), impact on quality-of-life (QOL), existing treatment paradigms and gaps, and NA medications currently used in treatment. Methods: Thirty-three thousand three hundred seventy-eight households were screened for individuals, ≥4 years old, with a physician diagnosis of AR or NA and either symptoms or treatment in the past 12 months. Standardized questionnaires were used to make comparisons across regions. A total of 1043 adults and 192 children were included in the survey. Results: Nine percent of participants were diagnosed with AR with two of three responding that their NAs were seasonal in nature. Nasal congestion was the most common and bothersome symptom of AR. Most participants reported that AR impacted their QOL with nearly one-half citing impairments in school/work performance/productivity. Sleep disturbances, secondary to AR, were also shown to be appreciable. Two-thirds of patients took medication for their AR. Less than one-quarter of survey respondents reported taking an intranasal corticosteroid and the satisfaction rate was similar to that of over-the-counter medications. The most common reasons cited for dissatisfaction were related to inadequate efficacy and bothersome side effects. Conclusion: AR appears to be extremely common across Asia - Pacific nations. Many individuals with AR suffer from symptoms that reduce QOL and treatment gaps exist with current therapies. Through identification of disease impact and highlighting treatment gaps, clinicians may better understand and treat AR, leading to improvements in overall patient satisfaction and QOL.",
author = "Katelaris, {Constance H.} and Lai, {Christopher K.W.} and Rhee, {Chae Seo} and Lee, {Sang Hag} and {De Yun}, Wang and Linda Lim-Varona and Quang, {Vo Thanh} and Jason Hwang and Harvinder Singh and Jungsoo Kim and Boyle, {John M.} and Dhong, {Hun Jong} and Prepageran Narayanan and Gil Vicente and Michael Blaiss and Raymond Sacks",
year = "2011",
month = "9",
day = "1",
doi = "10.2500/ajra.2011.25.3674",
language = "English",
volume = "25",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "5 SUPPL. 1",

}

TY - JOUR

T1 - Nasal allergies in the Asian - Pacific population

T2 - Results from the Allergies in Asia-Pacific Survey

AU - Katelaris, Constance H.

AU - Lai, Christopher K.W.

AU - Rhee, Chae Seo

AU - Lee, Sang Hag

AU - De Yun, Wang

AU - Lim-Varona, Linda

AU - Quang, Vo Thanh

AU - Hwang, Jason

AU - Singh, Harvinder

AU - Kim, Jungsoo

AU - Boyle, John M.

AU - Dhong, Hun Jong

AU - Narayanan, Prepageran

AU - Vicente, Gil

AU - Blaiss, Michael

AU - Sacks, Raymond

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Background: The Allergies in Asia - Pacific Survey describes the symptoms, impact, and treatment of allergic rhinitis (AR) across Australia, China, Hong Kong, Malaysia, Singapore, Taiwan, Vietnam, and the Philippines. The Allergies in Asia - Pacific Survey was undertaken to further clarify the prevalence of physician-diagnosed nasal allergies (NAs), impact on quality-of-life (QOL), existing treatment paradigms and gaps, and NA medications currently used in treatment. Methods: Thirty-three thousand three hundred seventy-eight households were screened for individuals, ≥4 years old, with a physician diagnosis of AR or NA and either symptoms or treatment in the past 12 months. Standardized questionnaires were used to make comparisons across regions. A total of 1043 adults and 192 children were included in the survey. Results: Nine percent of participants were diagnosed with AR with two of three responding that their NAs were seasonal in nature. Nasal congestion was the most common and bothersome symptom of AR. Most participants reported that AR impacted their QOL with nearly one-half citing impairments in school/work performance/productivity. Sleep disturbances, secondary to AR, were also shown to be appreciable. Two-thirds of patients took medication for their AR. Less than one-quarter of survey respondents reported taking an intranasal corticosteroid and the satisfaction rate was similar to that of over-the-counter medications. The most common reasons cited for dissatisfaction were related to inadequate efficacy and bothersome side effects. Conclusion: AR appears to be extremely common across Asia - Pacific nations. Many individuals with AR suffer from symptoms that reduce QOL and treatment gaps exist with current therapies. Through identification of disease impact and highlighting treatment gaps, clinicians may better understand and treat AR, leading to improvements in overall patient satisfaction and QOL.

AB - Background: The Allergies in Asia - Pacific Survey describes the symptoms, impact, and treatment of allergic rhinitis (AR) across Australia, China, Hong Kong, Malaysia, Singapore, Taiwan, Vietnam, and the Philippines. The Allergies in Asia - Pacific Survey was undertaken to further clarify the prevalence of physician-diagnosed nasal allergies (NAs), impact on quality-of-life (QOL), existing treatment paradigms and gaps, and NA medications currently used in treatment. Methods: Thirty-three thousand three hundred seventy-eight households were screened for individuals, ≥4 years old, with a physician diagnosis of AR or NA and either symptoms or treatment in the past 12 months. Standardized questionnaires were used to make comparisons across regions. A total of 1043 adults and 192 children were included in the survey. Results: Nine percent of participants were diagnosed with AR with two of three responding that their NAs were seasonal in nature. Nasal congestion was the most common and bothersome symptom of AR. Most participants reported that AR impacted their QOL with nearly one-half citing impairments in school/work performance/productivity. Sleep disturbances, secondary to AR, were also shown to be appreciable. Two-thirds of patients took medication for their AR. Less than one-quarter of survey respondents reported taking an intranasal corticosteroid and the satisfaction rate was similar to that of over-the-counter medications. The most common reasons cited for dissatisfaction were related to inadequate efficacy and bothersome side effects. Conclusion: AR appears to be extremely common across Asia - Pacific nations. Many individuals with AR suffer from symptoms that reduce QOL and treatment gaps exist with current therapies. Through identification of disease impact and highlighting treatment gaps, clinicians may better understand and treat AR, leading to improvements in overall patient satisfaction and QOL.

UR - http://www.scopus.com/inward/record.url?scp=80053452592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053452592&partnerID=8YFLogxK

U2 - 10.2500/ajra.2011.25.3674

DO - 10.2500/ajra.2011.25.3674

M3 - Article

C2 - 22185687

AN - SCOPUS:80053452592

VL - 25

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 5 SUPPL. 1

ER -